From FAP to B7-H3: What Determines Whether a Radiopharmaceutical Target Successfully Translates to the Clinic?

• Identifying the key biological, translational and clinical characteristics that differentiate high-potential radiopharmaceutical targets from those unlikely to succeed
• Exploring how target expression, tumour microenvironment interactions and biomarker strategies influence development decisions
• Understanding the role of preclinical modelling, radiobiology and imaging in strengthening confidence before clinical translation

Speakers: